Skip to main content
Site Logo

Download QR

Open Free Demat Account!

Join Our 9 Lakh Customers

+91
Headphone
HomeStocksAlembic Pharmaceuticals Ltd
Alembic Pharmaceuticals Ltd

Alembic Pharmaceuticals Ltd

Symbol:APLLTD
Small Cap
LTP810.95
-5.45 (-0.67%)
No chart data available for selected period

Fundamentals Ratios

Key Valuation Metrics

Market Cap₹15,963.87 Cr
P/E Ratio23.15
P/B Ratio2.84
Industry Ratio37.96
ROE11.89%
EPS (TTM)₹35.08
Dividend Yield1.48%
Book Value₹285.67
Face Value₹2
Sector P/E37.96
Outstanding Shares19.66 Cr
Beta0.88
Market Cap Type- -

Financial Statements

ParticularsMAR 2025MAR 2024MAR 2023MAR 2022
Sales Turnover6,672.086,228.635,652.625,305.79
Other Income56.328.32.7455.74
Total Revenue7,018.156,399.775,576.715,404.72
Total Expenditure5,953.625,439.084,896.524,474.82
Operating Profit1,064.53960.69680.19929.9
Interest78.7756.1950.1717.73
Gross Profit985.76904.5630.02912.17
Depreciation278.58272.67275.43286.78
Profit Before Tax707.18631.83354.59625.39
Tax122.6962.063.41127.92
Net Profit582.01615.82341.99520.94

About

Managing Director- -
Auditor NameKKC & Associates LLP
Founded2010
Parent OrganizationAlembic Pharmaceuticals Ltd

Price Summary

Open

₹806

Prev Close

₹816.4

Today's High

₹822

Today's Low

₹799.2

52W High₹998
52W Low₹635.8
Volume1,18,504
Traded ValueN/A

Shareholding Pattern

Foreign Promoters and Groups
Indian Promoters and Groups
Non-Promoter Institutions
Non-Promoter Non-Institutions

Data as per latest exchange filings*

Frequently Asked Questions

Common questions about this stock, answered from live data

As of 11 Sept 2026, 3:30 pm, the share price of Alembic Pharmaceuticals Ltd (APLLTD) is ₹810.95 on NSE and BSE.

Disclaimer: The FAQs above are generated based on historical and real-time market data provided by exchanges. This information is for educational purposes only and does not constitute financial advice, buy/sell recommendations, or price targets. Investment in the securities market is subject to market risks. Read all related documents carefully before investing.